[1]
I. N. Windiana, M. Iqhrammullah, L. P. L. Kamelia, I. N. G. N. Yanakusuma, K. D. K. Kesumaputri, and I. G. A. A. P. A. Yudana, “Genotype-Guided Dual Antiplatelet Therapy in CYP2C19 Loss-of-Function Carriers With Stroke or Transient Ischemic Attack: A Meta-Analysis of Ticagrelor–Aspirin Versus Clopidogrel–Aspirin”, J Neurol Res, vol. 16, no. 2, pp. 77–87, Jan. 2026, doi: 10.14740/jnr1101.